Nasus Pharma Ltd. (NSRX) Stock Ticker
NSRX right now
Market factors today
Unlock the full NSRX picture
About Nasus Pharma Ltd.
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
NSRX stock facts
| Ticker symbol | NSRX |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $30.0M |
| CEO | Brendan O'Grady |
| Employees | 7 |
| Headquarters | Tel Aviv, TA, IL |
| IPO date | 2025-08-13 |
| Website | www.nasuspharma.com |
What you can see for NSRX on Tickr
Live NSRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NSRX report.
Rankings
FAQ
What is the ticker symbol for Nasus Pharma Ltd.?
The ticker symbol for Nasus Pharma Ltd. is NSRX, listed on the New York Stock Exchange Arca.
What is NSRX?
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and…